El Mustapha Bahassi

2.1k total citations
39 papers, 1.6k citations indexed

About

El Mustapha Bahassi is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, El Mustapha Bahassi has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Cell Biology. Recurrent topics in El Mustapha Bahassi's work include DNA Repair Mechanisms (12 papers), Microtubule and mitosis dynamics (9 papers) and Cancer-related Molecular Pathways (8 papers). El Mustapha Bahassi is often cited by papers focused on DNA Repair Mechanisms (12 papers), Microtubule and mitosis dynamics (9 papers) and Cancer-related Molecular Pathways (8 papers). El Mustapha Bahassi collaborates with scholars based in United States, South Africa and Belgium. El Mustapha Bahassi's co-authors include Peter J. Stambrook, Martine Couturier, David L. Myer, Robert F. Hennigan, Philippe Bernard, William Z. Bernstein, P J Stambrook, Paul Hasty, Robert F. Koncar and Yolanda Sánchez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

El Mustapha Bahassi

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
El Mustapha Bahassi United States 22 1.1k 503 338 319 245 39 1.6k
María C. Garrido Spain 17 1.3k 1.2× 1.0k 2.0× 234 0.7× 176 0.6× 308 1.3× 43 2.2k
James T. Platt United States 19 882 0.8× 562 1.1× 203 0.6× 293 0.9× 272 1.1× 28 1.8k
Deog Su Hwang South Korea 23 1.3k 1.2× 248 0.5× 219 0.6× 501 1.6× 95 0.4× 40 1.5k
Virginie Baylot France 15 1.1k 1.0× 855 1.7× 114 0.3× 106 0.3× 292 1.2× 20 2.2k
Chonghui Cheng United States 24 2.0k 1.8× 584 1.2× 376 1.1× 114 0.4× 509 2.1× 35 2.4k
Manuela Vecchi Italy 27 1.5k 1.4× 1.0k 2.0× 351 1.0× 135 0.4× 531 2.2× 42 2.6k
Steven M. Picksley United Kingdom 22 1.5k 1.4× 975 1.9× 215 0.6× 335 1.1× 261 1.1× 30 2.1k
Norvin D. Fernandes United States 14 1.3k 1.2× 458 0.9× 200 0.6× 103 0.3× 188 0.8× 16 1.7k
Masamichi Ishiai Japan 36 2.7k 2.5× 679 1.3× 364 1.1× 469 1.5× 714 2.9× 67 3.7k
Annika Sääf Sweden 16 1.0k 0.9× 206 0.4× 120 0.4× 388 1.2× 394 1.6× 25 1.6k

Countries citing papers authored by El Mustapha Bahassi

Since Specialization
Citations

This map shows the geographic impact of El Mustapha Bahassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by El Mustapha Bahassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites El Mustapha Bahassi more than expected).

Fields of papers citing papers by El Mustapha Bahassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by El Mustapha Bahassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by El Mustapha Bahassi. The network helps show where El Mustapha Bahassi may publish in the future.

Co-authorship network of co-authors of El Mustapha Bahassi

This figure shows the co-authorship network connecting the top 25 collaborators of El Mustapha Bahassi. A scholar is included among the top collaborators of El Mustapha Bahassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with El Mustapha Bahassi. El Mustapha Bahassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raal, Frederick J., Vimal Mehta, Meral Kayıkçıoğlu, et al.. (2025). Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial. The Lancet Diabetes & Endocrinology. 13(3). 178–187. 6 indexed citations
3.
Lee, Denis, Matthew Kofron, Paul F. Lambert, et al.. (2021). Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory Papillomatosis. Viruses. 13(1). 68–68. 7 indexed citations
4.
5.
Koncar, Robert F., Sharon K. Michelhaugh, Fazlul H. Sarkar, et al.. (2015). Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma. Oncoscience. 2(7). 618–628. 44 indexed citations
6.
Bahassi, El Mustapha & Peter J. Stambrook. (2014). Next-generation sequencing technologies: breaking the sound barrier of human genetics. Mutagenesis. 29(5). 303–310. 84 indexed citations
7.
Salkeni, Mohamad A., et al.. (2013). Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients. Journal of Neuro-Oncology. 115(1). 27–35. 48 indexed citations
8.
Bahassi, El Mustapha, Yaqin Li, Trisha M. Wise‐Draper, et al.. (2013). A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer. European Journal of Cancer. 49(10). 2345–2355. 10 indexed citations
9.
Bahassi, El Mustapha, et al.. (2012). Targeting DNA repair mechanisms in cancer. Pharmacology & Therapeutics. 137(3). 298–308. 97 indexed citations
10.
Dai, Bojie, Xia Zhao, Krystyna Mazan-Mamczarz, et al.. (2011). Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma. Nature Communications. 2(1). 402–402. 50 indexed citations
11.
Myer, David L., Moying Yin, Gregory P. Boivin, et al.. (2011). Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 714(1-2). 1–10. 20 indexed citations
12.
Meyer, Sara E., Belinda E. Peace, El Mustapha Bahassi, et al.. (2010). Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice. Cancer Letters. 296(2). 186–193. 4 indexed citations
13.
Andrysík, Zdeněk, William Z. Bernstein, Li Deng, et al.. (2010). The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus. Nucleic Acids Research. 38(9). 2931–2943. 71 indexed citations
14.
Bahassi, El Mustapha, David L. Myer, Richard J. McKenney, Robert F. Hennigan, & Peter J. Stambrook. (2006). Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 596(1-2). 166–176. 46 indexed citations
15.
Myer, David L., El Mustapha Bahassi, & Peter J. Stambrook. (2005). The Plk3-Cdc25 circuit. Oncogene. 24(2). 299–305. 43 indexed citations
16.
Bahassi, El Mustapha, Saikumar Karyala, Craig R. Tomlinson, et al.. (2004). Critical regulation of genes for tumor cell migration by AP-1. Clinical & Experimental Metastasis. 21(4). 293–304. 40 indexed citations
17.
Bahassi, El Mustapha, David L. Myer, Robert F. Hennigan, et al.. (2002). Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene. 21(43). 6633–6640. 131 indexed citations
18.
Butow, Ronald A. & El Mustapha Bahassi. (1999). Adaptive thermogenesis: Orchestrating mitochondrial biogenesis. Current Biology. 9(20). R767–R769. 28 indexed citations
19.
Loris, Remy, Minh‐Hoa Dao‐Thi, El Mustapha Bahassi, et al.. (1999). Crystal structure of CcdB, a topoisomerase poison from E. coli 1 1Edited by T. Richmond. Journal of Molecular Biology. 285(4). 1667–1677. 120 indexed citations
20.
Bernard, Philippe, et al.. (1994). Positive-selection vectors using the F plasmid ccdB killer gene. Gene. 148(1). 71–74. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026